More Than Half of U.S. Adults Could Be Candidates for Ozempic

TUESDAY, Nov. 19, 2024 -- More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds.Sold as Ozempic for treating diabetes and Wegovy to spur weight loss...